Xenetic Biosciences, Inc. (XBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q3 '24: 614.2K Q4 '24: 648.8K Q1 '25: 593.3K Q2 '25: 589.9K Q3 '25: 1M Q4 '25: 766.3K Q1 '26: 806.9K Q2 '26: 660.6K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 350K 700K 1.1M Q2 '12: 36.4K Q2 '13: 29.5K Q2 '13: 1M Q3 '13: 0 Q4 '13: 0 Q1 '14: 0 Q1 '15: 0 Q2 '12 Q2 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q1 '15

Operating Income Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q3 '24: -499.5K Q4 '24: -1.1M Q1 '25: -942.4K Q2 '25: -724.4K Q3 '25: -544.7K Q4 '25: -623K Q1 '26: -502.1K Q2 '26: -971.7K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q3 '24: -436.7K Q4 '24: -1.1M Q1 '25: -903.1K Q2 '25: -688.7K Q3 '25: -509.9K Q4 '25: -579.1K Q1 '26: -456.4K Q2 '26: -929.7K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 35K 70K 105K Q1 '14: 0 Q1 '15: 0 Q2 '17: 59.1K Q3 '17: 97K Q2 '18: 0 Q3 '18: 0 Q1 '14 Q1 '15 Q2 '17 Q3 '17 Q2 '18 Q3 '18

Operating Cash Flow Quarterly

-1.1M -700K -350K 0 350K 700K 1.1M Q3 '24: -459K Q4 '24: -674K Q1 '25: -1M Q2 '25: -383.8K Q3 '25: -658.2K Q4 '25: -242.7K Q1 '26: -536.4K Q2 '26: -875.5K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-4M -2M 0 2M 4M 6M Q1 '17: 275.4K Q2 '17: -2M Q3 '17: -1.6M Q4 '17: 4.8M Q1 '18: -1.7M Q2 '18: -2.1M Q3 '18: -1.7M Q4 '18: -1M Q1 '17 Q2 '17 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 800K 1.6M 2.4M Q1 '24: 1.5M Q2 '24: 1.5M Q3 '24: 1.5M Q1 '25: 1.5M Q2 '25: 1.5M Q3 '25: 1.5M Q1 '26: 2.3M Q2 '26: 2.3M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '24: -2.66 Q4 '24: -2.57 Q1 '25: -2.38 Q2 '25: -2.00 Q3 '25: -2.05 Q4 '25: -1.59 Q1 '26: -1.20 Q2 '26: -1.16 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.